NR3C1 and breast cancer: Indeed, a retrospective meta-analysis of 1378 early stage ERα-negative BCs and 623 TNBCs confirmed that a high tumoral GR expression was significantly correlated with a shorter relapse-free survival in BC patients, whether undergoing treated or not with adjuvant chemotherapy [96,114].